Trademark: 79248879
Word
MINIT
Status
Registered
Status Code
700
Status Date
Tuesday, July 23, 2019
Serial Number
79248879
Registration Number
5809567
Registration Date
Tuesday, July 23, 2019
Mark Type
4000
Filing Date
Friday, July 20, 2018
Published for Opposition
Tuesday, May 7, 2019

Trademark Owner History
OXFORD NANOPORE TECHNOLOGIES LIMITED - Original Registrant

Classifications
9 Electronic sensing apparatus, namely, electronic devices for sensing and detecting analytes in scientific test samples for scientific testing purposes; apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, automated instruments for detecting the presence, properties and identity of analytes; portable apparatus and instruments for biological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs (application specific integrated circuits), and networked computer hardware and software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; scientific apparatus and instruments for use in DNA, RNA, protein and polynucleic acid sequencing; scientific apparatus for the analysis of polynucleic acid sequences; scientific apparatus and instruments for the analysis of nucleic and polynucleic acids; scientific apparatus and instruments for the analysis of proteins; scientific apparatus and instruments for analysis of genetic information, genomic information and proteomic information; apparatus and instruments for use in laboratory analysis, namely, empty cartridges for test samples, namely, cartridges for use with concentrates and solutions in solid or liquid form samples for scientific or research testing use; scientific apparatus, devices and instruments for synthesising chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; data processing apparatus, devices and instruments; apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; portable scientific apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; instruments and apparatus for the display of information obtained from scientific equipment; silicon chips; DNA chips; analyte detector chips; biosensor chips; batteries; rechargeable batteries; chargers for batteries; power packs in the nature of rechargeable battery packs; Nanopore sensing devices; Structural parts and fittings for all the aforesaid goods
10 Medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; portable medical and veterinary apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; liquid biopsy devices for medical and veterinary use; blood testing apparatus; diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable diagnostic apparatus for medical or veterinary purposes for pregnancy testing, and for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; Portable diagnostic apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; portable testing apparatus for medical or veterinary purposes for detecting pathogenic, infectious, psychiatric, oncogenic, metabolic, genetic, respiratory, genitourinary, digestive, inflammatory, autoimmune, reproductive, hepatic, central nervous system, degenerative and cardiovascular diseases or conditions; cartridges for test samples, for medical purposes; reaction units containing chemical reagents, for medical purposes
42 Scientific and technological services and research and design relating thereto, namely, consultation, research and design services relating to automated systems and instruments for direct electrical detection and analysis of molecules for application in the field of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; industrial analysis and research services in the fields of genomics, protein analysis, molecular analysis, life sciences, healthcare, security and defence; scientific research for chemical, biochemical, biological, bacteriological, medical or veterinary purposes; biological, chemical, biochemical, bacteriological, DNA, RNA, protein, polynucleic acid and molecular analysis services; services relating to the synthesis of chemical compounds, small molecules, genomes, DNA, RNA or other nucleic acids, oligosaccharides, proteins and peptides; scientific research for medical or veterinary purposes; genome, DNA, RNA and nucleic acid, oligosaccharide, protein and peptide synthesising services; chemical compound and small molecule synthesising services; DNA and RNA and polynucleic acid sequencing services; protein sequencing services; design and development of instruments and apparatus for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; laboratory testing services; DNA and polynucleic acid testing services; genome sequencing services; Analysis and evaluation of data, namely, scientific and medical data; overseeing, monitoring and managing scientific and medical experiments and tests; overseeing, monitoring and managing the analysis and evaluation of scientific and medical data; design of scientific experiments; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; provision of reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services; technical data analysis and evaluation services; electronic data storage services; application service provider (ASP) services for providing access to computer software applications installed or downloaded onto data processing apparatus, scientific apparatus, medical and veterinary apparatus, mobile phones and handheld mobile digital electronic devices; information, advisory and consultancy services relating to the aforesaid
MIN IT

Trademark Events
Nov 6, 2021
New Representative At Ib Received
Dec 1, 2019
Final Decision Transaction Processed By Ib
Nov 12, 2019
Final Disposition Notice Sent To Ib
Nov 12, 2019
Final Disposition Processed
Oct 25, 2019
New Representative At Ib Received
Oct 23, 2019
Final Disposition Notice Created, To Be Sent To Ib
Jul 23, 2019
Registered-Principal Register
May 7, 2019
Official Gazette Publication Confirmation E-Mailed
May 7, 2019
Published For Opposition
May 3, 2019
Notification Processed By Ib
Apr 17, 2019
Notification Of Possible Opposition Sent To Ib
Apr 17, 2019
Notification Of Notice Of Publication E-Mailed
Apr 17, 2019
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 18, 2019
Approved For Pub - Principal Register
Mar 18, 2019
Examiner's Amendment Entered
Mar 18, 2019
Notification Of Examiners Amendment E-Mailed
Mar 18, 2019
Examiners Amendment E-Mailed
Mar 18, 2019
Examiners Amendment -Written
Mar 7, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 7, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 16, 2019
Refusal Processed By Ib
Jan 26, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Jan 26, 2019
Refusal Processed By Mpu
Jan 15, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Jan 15, 2019
Application Filing Receipt Mailed
Jan 14, 2019
Non-Final Action Written
Jan 11, 2019
Assigned To Examiner
Jan 11, 2019
New Application Office Supplied Data Entered In Tram
Jan 3, 2019
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24